Glaukos Corp (GKOS)
144.12
+3.29
(+2.34%)
USD |
NYSE |
Nov 22, 11:13
Glaukos Profit Margin (Quarterly): -22.15% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -22.15% |
June 30, 2024 | -52.82% |
March 31, 2024 | -47.70% |
December 31, 2023 | -44.65% |
September 30, 2023 | -39.01% |
June 30, 2023 | -40.81% |
March 31, 2023 | -46.86% |
December 31, 2022 | -44.17% |
September 30, 2022 | -38.69% |
June 30, 2022 | -62.65% |
March 31, 2022 | 7.94% |
December 31, 2021 | -29.86% |
September 30, 2021 | 8.34% |
June 30, 2021 | -22.39% |
March 31, 2021 | -24.23% |
December 31, 2020 | -14.54% |
September 30, 2020 | -24.29% |
June 30, 2020 | -126.4% |
March 31, 2020 | -97.69% |
December 31, 2019 | 55.55% |
September 30, 2019 | -23.08% |
June 30, 2019 | -10.77% |
Date | Value |
---|---|
March 31, 2019 | -2.48% |
December 31, 2018 | 3.29% |
September 30, 2018 | -15.08% |
June 30, 2018 | -12.51% |
March 31, 2018 | -6.76% |
December 31, 2017 | 2.42% |
September 30, 2017 | 3.28% |
June 30, 2017 | -8.00% |
March 31, 2017 | 2.45% |
December 31, 2016 | 0.40% |
September 30, 2016 | 3.92% |
June 30, 2016 | 8.17% |
March 31, 2016 | 3.88% |
December 31, 2015 | -11.29% |
September 30, 2015 | -10.82% |
June 30, 2015 | -179.8% |
March 31, 2015 | -6.59% |
December 31, 2014 | -32.64% |
September 30, 2014 | -12.28% |
June 30, 2014 | -18.69% |
March 31, 2014 | -47.97% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-126.4%
Minimum
Jun 2020
55.55%
Maximum
Dec 2019
-35.35%
Average
-38.85%
Median
Profit Margin (Quarterly) Benchmarks
Boston Scientific Corp | 11.12% |
Baxter International Inc | 5.19% |
Masimo Corp | 1.94% |
Teleflex Inc | 14.52% |
Perspective Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -27.46% |
Return on Assets | -16.02% |
Return on Invested Capital | -20.29% |
Gross Profit Margin (Quarterly) | 76.64% |
Operating Margin (Quarterly) | -25.51% |
Return on Net Operating Assets | -24.35% |